Sign In
Buy VIVO
$5.74
-0.620 (-9.75%)
At Close: Jun 03, 2026
Follows recently announced share acquisitions totaling 2.65 million shares by board members, including Executive Chairman and CEO, Kevin Chin, who purchased the majority of shares
VivoPower begins share conversion program to reduce public float, bolster long-term alignment
06:16am, Friday, 20'th Mar 2026
VivoPower PLC (NASDAQ:VIVO, FRA:51J) said on Friday it has begun converting a portion of its publicly traded shares into a restricted class held by...
VivoPower Terminates $180 Million F-3 Registration Statement
09:00am, Wednesday, 18'th Mar 2026
Decision reflects commitment to a strategy of non dilutive funding Alternative potential capital sources available at project level LONDON, March 18, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (Nasdaq: VI
VivoPower shares jump as it terminates $180M F-3 registration statement
06:17am, Wednesday, 18'th Mar 2026
Shares of VivoPower PLC (NASDAQ:VIVO, FRA:51J) surged 23.3% on Wednesday morning after the company announced it had terminated its $180 million Form F-3...
VivoPower Announces Effectiveness of New Stock Ticker “VIVO” and Corporate Name Change
07:05am, Monday, 16'th Mar 2026
LONDON, March 16, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data cen
VivoPower adopts new Nasdaq ticker ‘VIVO’ and completes name change
05:30am, Monday, 16'th Mar 2026
VivoPower PLC (NASDAQ:VIVO, FRA:51J) announced that its shares will begin trading under the new ticker ‘VIVO’ on the Nasdaq Composite starting March 16,...
VivoPower Announces New Stock Ticker “VIVO” and Corporate Name Change in Alignment with its Business Focus on AI Data Centers
09:20am, Tuesday, 10'th Mar 2026
LONDON, March 10, 2026 (GLOBE NEWSWIRE) -- VivoPower International PLC (Nasdaq: VVPR) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data cen
Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia
08:00am, Tuesday, 20'th Jan 2026
FORT MILL, S.C., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the ca
Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO
08:30am, Monday, 21'st Oct 2024
FORT MILL, SC / ACCESSWIRE / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac
Catheter Precision Continues to Expand Clinical Data and Acceptance of VIVO
08:30am, Wednesday, 02'nd Oct 2024
FORT MILL, SC / ACCESSWIRE / October 2, 2024 / Catheter Precision, Inc. (NYSE/American:VTAK), a company dedicated in the development and marketing of technologically advanced products for the cardiac
Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients
09:00am, Thursday, 05'th Sep 2024
FORT MILL, SC / ACCESSWIRE / September 5, 2024 / Catheter Precision, Inc. (NYSE American:VTAK) today announced that at the recently held European Society of Cardiology (ESC) Symposium, interim results
FORT MILL, SC / ACCESSWIRE / July 16, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company, announced today that the patient follow-up phase for the VIVO
Catheter Precision, Inc. Announces Receipt of First Purchase Order for VIVO from Distributor in Middle East
08:00am, Thursday, 20'th Jun 2024
FORT MILL, SC / ACCESSWIRE / June 20, 2024 / Catheter Precision, Inc. (the "Company") (NYSE American:VTAK), a US based innovative medical device company announced that it has received its first purcha
- OCM™ was significantly better than comparators at halting proliferation of MRSA and PA –- OCM™ recorded the lowest bacterial counts of any treatment arm –- OCM™ showed significantly faster
Medical Devices Stock Pumps Up Buy Point With New Innovations
05:15pm, Thursday, 17'th Nov 2022
After launching three new products and posting a second quarter of rising EPS growth, medical devices leader Merit Medical Systems is probing a new buy point. The post Medical Devices Stock Pumps Up B
